Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that harness the full breadth of the immune system to protect ...

Invivyd, SPEAR Study Group to assess the effects of monoclonal antibody therapy for recent Covid & Covid-19 post-vaccination syndrome: Waltham, Massachusetts Saturday, July 5, 202 ...

But one thing is becoming clear: antibodies might not be telling the whole story when it comes to COVID-19 immunity. “We shouldn’t just look blindly at antibody tests,” Aleman says.

Recent vaccination announcements have led to some confusion. Four physicians weigh in on who should get vaccinated and when ...

The Centers for Disease Control and Prevention's vaccine advisory committee is set to meet for the first time since Health ...

Vermont has the second lowest state fatality rate in the US (148.2 per 100K; Hawaii 113.6/100K). Mississippi (465.8/100K) and ...

NB.1.8.1 is one of the latest variants of COVID-19, a "slightly upgraded version" of the LP.8.1 variant that is prominent ...

Inventprise, a clinical stage vaccine invention company, today announced the publication of a landmark preclinical study in ...

The use of TNF-α inhibitors among patients with hidradenitis suppurativa did not affect seroconversion following mRNA vaccination for COVID-19.

Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that clamp the spike at its base. Nature Communications, 2025; 16 (1) DOI: 10.1038/s41467-025-60250-1 ...

NB.1.8.1 is one of the latest variants of COVID-19, a "slightly upgraded version" of the LP.8.1 variant that is prominent right now, Subhash Verma, microbiology and immunology professor at the ...

A new, highly contagious Covid-19 strain has emerged globally as thousands of Australians prepare to travel overseas.